BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/16/2026 8:22:56 AM | Browse: 106 | Download: 469
 |
Received |
|
2025-10-20 09:40 |
|
Peer-Review Started |
|
2025-10-20 09:40 |
|
First Decision by Editorial Office Director |
|
2025-10-31 09:20 |
|
Return for Revision |
|
2025-10-31 09:20 |
|
Revised |
|
2025-11-14 06:51 |
|
Publication Fee Transferred |
|
2025-11-27 01:34 |
|
Second Decision by Editor |
|
2026-01-12 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-12 08:30 |
|
Articles in Press |
|
2026-01-12 08:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-27 23:54 |
|
Publish the Manuscript Online |
|
2026-03-16 08:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hye Yeon Chon, Hyungjin Rhee, Jeehoon Kim, Galam Leem, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Seung Up Kim and Hee Seung Lee |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea (NRF) and Funded by the Korean Government (MIST) |
No. RS-2024-00342475 |
| National Research Foundation of Korea (NRF) and Funded by the Korean Government (MIST) |
No. RS-2024-00335625 |
| Korea Health Technology RD Project Through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, Republic of Korea |
No. RS-2025-25458830 |
| Korea Health Technology RD Project Through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, Republic of Korea |
No. RS-2025-25459146 |
|
| Corresponding Author |
Hee Seung Lee, Professor, Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea. lhs6865@yuhs.ac |
| Key Words |
Hepatic steatosis; Pancreatic cancer; Liver metastases; Hepatic steatosis index; Metabolic dysfunction-associated steatotic liver disease |
| Core Tip |
Pancreatic cancer frequently spreads to the liver, contributing to its high mortality. With the rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), its potential impact on cancer outcomes remains uncertain. In this large cohort study of 2123 patients with pancreatic cancer, MASLD-defined by a hepatic steatosis index, was not associated with liver metastasis at diagnosis, new liver metastasis during follow-up or overall survival after adjustment for other risk factors. These findings suggest that MASLD does not significantly influence the metastatic pattern or prognosis in patients with pancreatic cancer. |
| Publish Date |
2026-03-16 08:22 |
| Citation |
Chon HY, Rhee H, Kim J, Leem G, Jo JH, Chung MJ, Park JY, Bang S, Park SW, Kim SU, Lee HS. Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer. World J Gastroenterol 2026; 32(11): 115488
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i11/115488.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i11.115488 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
